Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:32:59.940Z.
Calculation as of: 2026-10-06T17:32:59.940Z.
Quote observation: 2026-10-06T17:30:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 347a41eedf46a91d1f1a35dde2c997a021a555167078676fef94c90a8032fb0d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
MiniMed Group, Inc. Common Stock
Market Cap
$5.49B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.28B
EV/FCF Ratio
N/A
TTM Avg
10.43x
3Y Avg
10.43x
5Y Avg
10.43x
Market Cap
$5.27B
EV/FCF Ratio
63.68x
TTM Avg
65.85x
3Y Avg
83.67x
5Y Avg
71.38x
Market Cap
$5.74B
EV/FCF Ratio
30.44x
TTM Avg
30.49x
3Y Avg
54.15x
5Y Avg
54.33x
Market Cap
$5.22B
EV/FCF Ratio
N/A
TTM Avg
11.36x
3Y Avg
56.18x
5Y Avg
56.18x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $5.49B | N/A | N/A | N/A | N/A |
| RadNet, Inc. (RDNT)vs › | $5.53B | N/A | 97.76x | 95.40x | 108.34x |
| CG Oncology Inc. (CGON)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.30B | 16.82x | 20.97x | 34.66x | 46.39x |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.28B | N/A | 10.43x | 10.43x | 10.43x |
| Sotera Health Company (SHC)vs › | $5.27B | 63.68x | 65.85x | 83.67x | 71.38x |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.74B | 30.44x | 30.49x | 54.15x | 54.33x |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | N/A | 11.36x | 56.18x | 56.18x |
| Kodiak Sciences Inc. (KOD)vs › | $5.77B | N/A | N/A | N/A | N/A |
| Cogent Biosciences, Inc. (COGT)vs › | $5.17B | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute